That this BMJ article is correct and this particular part of the trial was botched by the contractor who covered it up, and the BMJ is unsatisfied with the level of follow-up by the FDA.
That the other trial sites were well managed and valid, that the results at this trial site do not overturn the overall results, and that the FDI found it unnecessary to investigate further.
That this BMJ article is correct and this particular part of the trial was botched by the contractor who covered it up, and the BMJ is unsatisfied with the level of follow-up by the FDA.
That the other trial sites were well managed and valid, that the results at this trial site do not overturn the overall results, and that the FDI found it unnecessary to investigate further.